Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients
Introduction: The scheme proton pump inhibitor/amoxicillin/clarithromycin (PPI/AC) is still the first-line treatment for Helicobacter pylori (H. pylori) infections despite evidence suggesting its failure in up to 20% to 30% of patients. Methodology: This study involved 493 patients who were prescrib...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2010
|
| 在線閱讀: | https://doi.org/10.3855/jidc.911 https://jidc.org/index.php/journal/article/download/21252448/463 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|